| Code | 3836D | ||||||||||
| MA number | 18/0058/20-S | ||||||||||
| Product Form: | tbl flm 28x25 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TAD Pharma GmbH, Germany | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 22.04.2020 |
| Dokument: |
VHS_súhrn_Sitagliptin TAD 18_0058-60_20-S.pdf
|
| Dokument: |
VHS_Sitagliptin TAD 18_0058-60_20-S.pdf
|
| SPC: |
SPC_Sitagliptin TAD filmom obalene tablety_06.2024.pdf
|
| PIL: |
PIL_Sitagliptin TAD filmom obalene tablety_06.2024.pdf
|
| Safety feature | Yes |
| Data update: | 28.08.2024 |
